Word size
Warren Buffett, CEO of Berkshire Hathaway
Warren Buffett’s
Berkshire Hathaway
Has confirmed that its holdings have been trimmed
Apple
Stock in the third quarter. Group launches positions in drug giants
AbbVie,
Pfizer,
And
Merck,
And reduced its stake in
JPMorgan Chase.
Berkshire Hathaway (ticker:
BRK.B
) Disclosed the trades, among others, in a form filed Monday with the Securities and Exchange Commission. The company did not respond to a request for comment.
Baron’s Earlier this month, Berkshire Hathaway was reported to have sold approximately 38 million shares of Apple (AAPL). The latest filing shows that Berkshire Hathaway sold 36.3 million shares in the quarter according to our report. It has 944.3 million shares of Apple as of Septe30.
Berkshire Hathaway also revealed that it has 3.7 million Pfizer (PFE) shares, 22.4 million Merck (MRK) shares and 21.3 million AbbVie (ABBV) shares as of the end of September. It did not have any of those companies at the end of June.
Buffett’s firm also sold 21.2 million JP Morgan shares, ending the third quarter with only 967,267 shares. The bank’s stock has slipped 16% this year.
Inside Scoop features a regular baronet that covers stock transactions by corporate executives and board members – so-called insiders as well as large shareholders, politicians and other key figures. Due to their internal position, these investors are required to disclose stock trades with the Securities and Exchange Commission or other regulatory groups.
Write Ed lin Follow more at [email protected] @BarronsEdLin.
.